Brief: Gland Pharma Gets EIR From USFDA For Pashamylaram Facility
24/11/2023 04:53
Nov 24 (Reuters) - Gland Pharma Ltd GLAD.NS :
* RECEIPT OF EIR FROM USFDA FOR COMPANY''S PASHAMYLARAM
FACILITY
Source text for Eikon: ID:nBSE7rQn5h
Further company coverage: GLAD.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gland Pharma
See all newsIndia Stocks: Indian shares open higher as Fed-hike fears, oil prices ease; financials lead
India Stocks: Indian shares poised to rebound as Fed-hike fears, oil prices ease
Brief: Gland Pharma Approves $21 Million Investment In Gland Pharma Usa
Brief: Fosun Pharma Says Unit Sold Gland Pharma Shares for $294 Mln
India's Gland Pharma gains on successful completion of US FDA probe at Visakhapatnam plant